Amplia Therapeutics Ltd.ASX: ATX

Positive Response from US FDA to Amplia's Type D Meeting

Nov 20, 2025 at 4:20 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment